2-(Diethylamino)ethyl 4-amino-3-butoxy-benzoate

CAS: 99-43-4

Ref. 3D-AAA09943

Product Information

• Name: 2-(Diethylamino)ethyl 4-amino-3-butoxy-benzoate
• Synonyms: 2-(Diethylamino)ethyl 4-amino-3-butoxybenzoate, 2-Diethylaminoethyl 4-amino-3-butoxybenzoate, 3-Butoxy-4-aminobenzoic acid 2-diethylaminoethyl ester, 4-Amino-3-butoxy-2-(diethylamino)ethyl ester benzoic acid, 4-Amino-3-butoxybenzoic acid 2-diethylaminoethyl ester, 4-Amino-3-n-butoxy-benzoesaeure-diaethylaminoaethylester, 4-Amino-3-n-butoxy-benzoesaeure-diaethylaminoaethylester [German], Benoxil, Benoxinate, Benzoic acid, 4-amino-3-butoxy-, 2-(diethylamino)ethyl ester, Brn 2288926, Butoxyaminobenzoyldiethylaminoethanol, Conjucain, Dorsacain, Novesinol, Oxibuprocaina, Oxibuprocaina [INN-Spanish], Oxibuprocainum, Oxibuprokain, Oxybucaine, Oxybuprocaine [INN:BAN], Oxybuprocainum, Oxybuprocainum [INN-Latin], Oxyriprocaine, Prescaina, S 749, Unii-Axq0Jym303, Oxybuprocaine

Description

2-(Diethylamino)ethyl 4-amino-3-butoxy-benzoate is a compound which has been shown to inhibit the binding of substance P to its receptor, the neurokinin-1 receptor. It was found in a model system that 2-(Diethylamino)ethyl 4-amino-3-butoxy-benzoate is able to reduce corneal edema and body formation by inhibiting the production of substance P. This compound also has anesthetic properties. The anesthetic effect of 2-(Diethylamino)ethyl 4-amino-3-butoxy-benzoate was determined using human serum. In vitro experiments have revealed that this compound is able to inhibit the binding of substance P to its receptor, the neurokinin 1 receptor, in a dose dependent manner. Additionally, it has been shown that this compound does not affect the binding of substance P at concentrations higher than those required for anesthesia.

• Brand: Biosynth

Chemical properties

• Molecular weight: 308.4 g/mol
• Formula: C₁₇H₂₈N₂O₃
• Purity: Min. 95%